Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

Health IT groups want more time to prepare for MACRA

Electronic health record (EHR) vendors and the clinicians they serve need more than a few months to adapt to the Medicare Access and CHIP Reauthorization Act, according to numerous comments submitted to CMS by health IT groups.

Collegium CEO Michael Heffernan Named EY Entrepreneur of the Year

CANTON, Mass., June 27, 2016 (GLOBE NEWSWIRE) -- EY announced that Collegium’s CEO, Michael Heffernan, received the EY Entrepreneur of the Year® 2016 Award in the Life Sciences and Healthcare category in New England. This year marks the 30th anniversary of the EY Entrepreneur of the Year Award program. The award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities. Winners were selected by an independent panel of judges, and the award was presented at a special gala event at the Marriott Copley Place on June 23, 2016.

Thumbnail

MACRA comments urge CMS to push back start date

Delaying the schedule start for reporting under new payment models set up after passage of the Medicare Access and CHIP Reauthorization Act (MACRA) was one of several common suggestions included in comments on CMS’s proposed rule.  

12 executive moves from June

A list of top executive happenings in June.

Home health would see $180 million Medicare cut under CMS proposal

CMS is proposing a 1 percent reduction in reimbursements for home healthcare agencies for 2017, amounting to an overall cut in payment of $180 million.

NYU shuts down medical studies over drug violations

Use of relatively untested drugs on patients with serious mental health issues, along with incomplete case histories and falsified records, led New York University’s medical school to end eight psychiatric studies.

Doctors develop computer simulation for spleen's filtering process

Researchers have created a new computer model that is able to show how the tiny slits in the spleen filter diseased or misshapen red blood cells from re-entering the bloodstream. 

EPA OKs drinking filtered water in Flint as CDC releases report detailing effects on children

It’s finally OK to drink the tap water in Flint, Mich.—but only if it’s filtered, according to a June 23 announcement from the Environmental Protection Agency.

Displaying 5881 - 5888 of 8456

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.